Literature DB >> 7841389

Nicotine protects cultured striatal neurones against N-methyl-D-aspartate receptor-mediated neurotoxicity.

P Marin1, M Maus, S Desagher, J Glowinski, J Prémont.   

Abstract

The role of cholinergic mechanisms in N-methyl-D-aspartate (NMDA)-mediated neuronal death was investigated using mouse striatal neurones in primary culture. A 30 min exposure of striatal neurones to increasing concentrations of NMDA resulted 24 h later in dramatic neuronal degeneration as assessed by MTT staining, crystal violet incorporation and determination of microtubule-associated protein 2. The NMDA-induced neurodegeneration was strongly inhibited by the co-application of two non-selective cholinergic agonists, acetylcholine or carbachol. This protective effect appears to be mediated by nicotinic receptors since it was insensitive to the muscarinic antagonist atropine but mimicked by nicotine, nornicotine and 1,1-dimethyl-4-phenyl-piperazinium. Moreover, the nicotine-evoked neuroprotection was inhibited by the central nicotinic antagonist hexamethonium. Therefore, this study suggests that cholinergic interneurones play an important role in neuronal survival in the striatum.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7841389     DOI: 10.1097/00001756-199410000-00035

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  15 in total

1.  Increased neurodegeneration during ageing in mice lacking high-affinity nicotine receptors.

Authors:  M Zoli; M R Picciotto; R Ferrari; D Cocchi; J P Changeux
Journal:  EMBO J       Date:  1999-03-01       Impact factor: 11.598

2.  [Neurodegeneration and neuroprotection].

Authors:  K-G Schmidt
Journal:  Ophthalmologe       Date:  2004-11       Impact factor: 1.059

3.  Calcium preconditioning triggers neuroprotection in retinal ganglion cells.

Authors:  S K Brandt; M E Weatherly; L Ware; D M Linn; C L Linn
Journal:  Neuroscience       Date:  2010-10-31       Impact factor: 3.590

Review 4.  Nicotinic system involvement in Alzheimer's and Parkinson's diseases. Implications for therapeutics.

Authors:  P A Newhouse; A Potter; E D Levin
Journal:  Drugs Aging       Date:  1997-09       Impact factor: 3.923

5.  Striatal increase of neurotrophic factors as a mechanism of nicotine protection in experimental parkinsonism.

Authors:  R Maggio; M Riva; F Vaglini; F Fornai; G Racagni; G U Corsini
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

6.  Nicotinic receptor-induced apoptotic cell death of hippocampal progenitor cells.

Authors:  F Berger; F H Gage; S Vijayaraghavan
Journal:  J Neurosci       Date:  1998-09-01       Impact factor: 6.167

7.  Acquisition and long-term retention of spatial learning in the human immunodeficiency virus-1 transgenic rat: effects of repeated nicotine treatment.

Authors:  Michael Vigorito; Junran Cao; Ming D Li; Sulie L Chang
Journal:  J Neurovirol       Date:  2013-03-02       Impact factor: 2.643

8.  Neuroprotection of rat retinal ganglion cells mediated through alpha7 nicotinic acetylcholine receptors.

Authors:  K Iwamoto; D Mata; D M Linn; C L Linn
Journal:  Neuroscience       Date:  2013-02-10       Impact factor: 3.590

9.  Presynaptic involvement in the nicotine prevention of the dopamine loss provoked by 6-OHDA administration in the substantia nigra.

Authors:  J Andrés Abin-Carriquiry; Ronald McGregor-Armas; Gustavo Costa; Jessika Urbanavicius; Federico Dajas
Journal:  Neurotox Res       Date:  2002-03       Impact factor: 3.911

Review 10.  Tobacco nitrosamines as culprits in disease: mechanisms reviewed.

Authors:  Emine Yalcin; Suzanne de la Monte
Journal:  J Physiol Biochem       Date:  2016-01-14       Impact factor: 4.158

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.